Mit Magzter GOLD unbegrenztes Potenzial nutzen
Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur
Versuchen GOLD - Frei
'CDSCO's labelling reforms a constructive step for globally aligned ecosystem'
Chronicle Pharmabiz
|January 15, 2026
INDIAN pharmaceutical companies have taken note of the CDSCO recent labelling reforms, viewing them as a constructive step toward building a more globally aligned pharmaceutical ecosystem.
Saransh Chaudhary, president, global critical care, Venus Remedies and CEO, Venus Medicine Research Centre pointed out that better labelling can drive India's push for safer and globally competitive pharma products. To this end, the recent decision by CDSCO is a long-awaited step that could meaningfully reshape how patients interact with medicines in India and abroad.
Diese Geschichte stammt aus der January 15, 2026-Ausgabe von Chronicle Pharmabiz.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Chronicle Pharmabiz
Chronicle Pharmabiz
Experts recommend ending inverted duty structure in Budget
EXPERTS have recommended eliminating inverted duty structure, incentives for research, health-tech startups among others in Union Budget 2026.
2 mins
January 15, 2026
Chronicle Pharmabiz
India crosses milestone of 50,000 NQAS certifications
THE Government of India has announced that a total of 50,373 public health facilities across all states and Union Territories in the country have been certified under the National Quality Assurance Standards (NQAS) - a comprehensive quality framework established by the ministry of health and family welfare (MoHFW) - as on December 31, 2025.
1 min
January 15, 2026
Chronicle Pharmabiz
Utilise Their Expertise
THE MIT Pharmacy College in Mysuru has recently urged the Union Health Ministry to include Pharm D (Doctor of Pharmacy) graduates in the eligibility criteria for the post of Drug Inspectors and Food Inspectors. In July 2019, the Union Health Ministry had issued a gazette notification clearly stating that a person holding the Pharm D qualification, being a higher qualification, shall automatically become eligible for appointment to various posts where a person holding Diploma in Pharmacy or Bachelor of Pharmacy or Master of Pharmacy qualification is eligible to be appointed. Further, as Pharm D is an approved qualification under the Pharmacy Act, 1948, the Pharmacy Council of India has continuously been requesting the Central and State governments to amend recruitment rules to include Pharm D for various posts. More importantly, the Drugs Technical Advisory Board (DTAB), the highest authority under the Union Health Ministry on technical matters, has reportedly agreed to amend the Drugs & Cosmetics Rules, 1945, to explicitly include Pharm D for the qualifications of inspectors. But, the fact remains that there is still inconsistent application of the Pharm D qualification for key public health posts across the country, specifically the Drug Inspectors and Food Inspectors roles. It is deplorable that even though Pharm D is a higher and more extensive qualification than B Pharm and M Pharm, its automatic eligibility is frequently disregarded by various recruiting agencies in the country including Union Public Service Commission and State Public Service Commissions.
1 mins
January 15, 2026
Chronicle Pharmabiz
IPC's relaunch of toll-free helpline as a multilingual IVRS to improve ADRs
THE Indian Pharmacopoeia Commission (IPC)'s re-launch of its toll-free helpline (1800-180-3024) as an advanced multilingual Interactive Voice Response System (IVRS), through the Pharmacovigilance Programme of India (PVPI), has been designed to improve medicine related adverse drug reaction (ADR) reporting and enhance patient safety, according to officials associated with the development.
1 mins
January 15, 2026
Chronicle Pharmabiz
AiMeD asks govt to hike import tariffs from 7.5% to 10-15% to boost domestic mfg
THE Association of Indian Medical Device Industry (AiMeD) has urged the Central Government to consider raising import tariffs to 10 to 15 per cent from the current 7.5 per cent, adopt quality-based criteria in public procurement with preference for Indian Certification for Medical Devices (ICMED) certification over foreign approvals, and updating labelling norms to disclose domestic content percentage and incentivise local value addition, in the upcoming Union Budget 2026-27.
2 mins
January 15, 2026
Chronicle Pharmabiz
Dr Reddy's launches recombinant vaccine for HEV prevention
DR Reddy's Laboratories has launched a novel Hevaxin, recombinant vaccine for the prevention of hepatitis E virus (HEV) infection in India. Hevaxin is the only vaccine approved by the Drug Controller General of India (DCGI) for the indication of active immunization against HEV infection in adults aged 18 to 65 years in India.
1 mins
January 15, 2026
Chronicle Pharmabiz
'India falls short of global norms in pharmacist-supervised OTC drug dispensing'
INDIA falls short of global norms for pharmacist-supervised OTC (over the counter) drug dispensing, as these medicines are frequently sold without the involvement of a qualified, registered pharmacist. In many developed and emerging healthcare systems, pharmacist supervision is a regulatory requirement to ensure appropriate medicine selection, prevent misuse, manage drug interactions, and enhance patient safety.
1 min
January 15, 2026
Chronicle Pharmabiz
Year 2025's concerning dry eye disease to pave way for monitoring in 2026
DRY eye disease became a widespread concern in 2025, fuelled by urban pollution, extended screen time, and air-conditioned environments. Patients reported burning, irritation, and blurred vision, while younger populations reported digital eye strain.
2 mins
January 15, 2026
Chronicle Pharmabiz
DCA Telangana raids illegal clinic in Hanumakonda
THE Drugs Control Administration (DCA) of Telangana conducted a targeted raid on an illegal clinic in Dameral Village at Elkathurthi Mandal in Hanumakonda District, on Tuesday, January 6.
1 mins
January 15, 2026
Chronicle Pharmabiz
Govt may exempt 11 drugs from procurement rules
THE Department of Pharmaceuticals (DoP) has proposed to add 11 more drugs including insulin and monoclonal antibodies to the list of 84 drug formulations it has mentioned in November, 2025, to be exempted from Global Tender Enquiry (GTE), under the General Financial Rules, 2017, for tenders up to Rs. 200 crore.
1 min
January 15, 2026
Listen
Translate
Change font size